Medicure MCUJF
OTC MCUJF
$0.92 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Medicure (MCUJF) EBITDA Margin (2009 - 2026)

Medicure (MCUJF) posted quarterly EBITDA Margin of 20.06% for Q1 2026, up 3200.0% year-over-year from 0.61% in Q1 2025, and up 2125.38% quarter-over-quarter from 0.9% in Q4 2025.

Medicure (MCUJF) EBITDA Margin (2009 - 2026) Analysis & Trends

Medicure's EBITDA Margin history runs 18 years deep, the most recent figure standing at 20.06% for Q1 2026.

  • In Q1 2026, EBITDA Margin rose 3200.0% year-over-year to 20.06%; the TTM figure through Mar 2026 stood at 6.0% (up 2190.0% YoY), while the FY2025 annual figure was 23.87%, down 1138.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 20.06%, up from 0.9% in the prior quarter.
  • The five-year high for EBITDA Margin was 92.89% in Q1 2023, with the low at 22.45% in Q3 2024.
  • The 5-year median for EBITDA Margin is 1.36% (2023), against an average of 9.59%.
  • The sharpest annual moves came in 2022 and 2024: EBITDA Margin soared 8090 bps in 2022, then plunged 9223 bps in 2024.
  • Medicure's EBITDA Margin stood at 85.73% in 2022, then plunged by 93 bps to 6.29% in 2023, then plunged by 235 bps to 8.48% in 2024, then soared by 111 bps to 0.9% in 2025, then jumped by 2125 bps to 20.06% in 2026.
  • Business Quant data shows MCUJF's EBITDA Margin at 20.06% in Q1 2026, 0.9% in Q4 2025, and 10.9% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Haleon 44.40 Bn 43.44 Bn - -
2 Teva Pharmaceutical Industries 43.75 Bn 40.09 Bn 2.15 Bn -5.58%
3 Zoetis 32.30 Bn 30.62 Bn 1.05 Bn 33.91%
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn 16.51%
5 United Therapeutics 21.97 Bn 19.31 Bn 683.80 Mn 42.23%
6 Viatris 18.90 Bn 18.02 Bn 1.46 Bn 0.17%
7 Neurocrine Biosciences 15.54 Bn 15.16 Bn 935.80 Mn 15.80%
8 Elanco Animal Health 11.94 Bn 11.41 Bn 798.00 Mn 18.13%
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - -
10 Medicure 96.01 Mn 94.89 Mn 2.57 Mn 20.06%

Historic Data

Download Data
DateValue
Mar 31, 2026 20.06%
Dec 31, 2025 0.90%
Sep 30, 2025 10.90%
Jun 30, 2025 -10.48%
Mar 31, 2025 -11.94%
Dec 31, 2024 -8.48%
Sep 30, 2024 -22.45%
Jun 30, 2024 -21.65%
Mar 31, 2024 0.67%
Dec 31, 2023 6.29%
Sep 30, 2023 1.82%
Jun 30, 2023 5.46%
Mar 31, 2023 92.89%
Dec 31, 2022 85.73%
Sep 30, 2022 4.56%
Jun 30, 2022 -0.77%
Dec 31, 2021 4.84%
Sep 30, 2021 -14.74%
Jun 30, 2021 -17.60%
Mar 31, 2021 37.34%